Oscar Health, Inc. (OSCR) — Financial statements
Income statement, balance sheet, and cash flow for Oscar Health, Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 11,701↑27.5% | 9,178↑56.5% | 5,863↑42.1% | 4,126↑114.8% | 1,921 | |
| Cost of Revenue | 10,019↑36.6% | 7,333↑58.0% | 4,642 | 0.00 | 0.00 | |
| Gross Profit | 1,682↓8.8% | 1,845↑51.1% | 1,221↓70.4% | 4,126↑114.8% | 1,921 | |
| Operating Expenses | ||||||
| R&D Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| General & Administrative Expenses | 2,050 | 0.00 | 0.00↓100.0% | 1,419↑435.5% | 265 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 2,050 | 0.00 | 0.00↓100.0% | 1,419↑435.5% | 265 | |
| Other Expenses | 29↓98.4% | 1,788↑22.7% | 1,456↓56.1% | 3,316↑48.9% | 2,226 | |
| Operating Expenses | 2,079↑16.3% | 1,788↑22.7% | 1,456↓69.2% | 4,736↑90.1% | 2,492 | |
| Total Costs & Expenses | 12,098↑32.6% | 9,120↑49.6% | 6,098↑28.8% | 4,736↑90.1% | 2,492 | |
| Operating Results | ||||||
| Operating Income | -396↓792.1% | 57↑124.3% | -236↑61.4% | -610↓6.9% | -571 | |
| Depreciation & Amortization | 29↓10.1% | 32↑4.7% | 31↑100.8% | 15↑4.6% | 15 | |
| EBITDA | -391↓537.9% | 89↑142.1% | -212↑62.9% | -572↓3.8% | -551 | |
| EBIT | -420↓834.2% | 57↑123.6% | -243↑58.7% | -587↓3.8% | -566 | |
| Interest & Other Income | ||||||
| Net Interest Income | -18↑25.8% | -24↑3.5% | -25↓8.8% | -23↓379.3% | -5 | |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Interest Expense | 18↓25.8% | 24↓3.5% | 25↑8.8% | 23↑379.3% | 5 | |
| Non-Operating Income | 23↑22127.6% | 0.11↓98.5% | 7↑131.3% | -23↓379.3% | -5 | |
| Other Income / Expenses | -41↓71.7% | -24↑24.8% | -32 | 0.00 | 0.00 | |
| Income Before Tax | -437↓1408.3% | 33↑112.5% | -267↑56.2% | -610↓6.9% | -571 | |
| Income Tax Expense | 6↓23.3% | 7↑121.8% | 3↑729.8% | -0.52↓161.8% | 0.85 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -443↓1795.6% | 26↑109.7% | -271↑55.6% | -610↓6.7% | -571 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -443↓1842.5% | 25↑109.4% | -271↑55.3% | -606↓5.9% | -573 | |
| Bottom-Line Net Income | -443↓1842.5% | 25↑109.4% | -271↑55.3% | -606↓5.9% | -573 | |
| EPS (Basic) | -1.69↓1636.4% | 0.11↑109.0% | -1.22↑57.2% | -2.85↑10.7% | -3.19 | |
| EPS (Diluted) | -1.69↓1865.9% | 0.10↑107.8% | -1.22↑57.2% | -2.85↑10.7% | -3.19 | |
| Weighted Average Shares | 262↑9.2% | 240↑8.5% | 222↑4.3% | 212↑18.7% | 179 | |
| Weighted Average Diluted Shares | 262↓1.3% | 266↑19.9% | 222↑4.3% | 212↑18.7% | 179 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.